Pfizer Ventures

All recorded activity

By stage

Seed2

Series A1

Series B1

Undisclosed1

Biotech5

United States2

China1

France1

United Kingdom1

5 in all activity

Jun 23

Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases

$47MSeed+

Role not disclosed

Mar 18

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

$77MSeries B

Role not disclosed

Jan 27

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosed

Role not disclosed

Jan 12

Develops intelligent, logic-gated therapeutics for solid tumors

$61MSeries A

Role not disclosed

Jan 8

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Role not disclosed